6A60 - Bipolar Disorder Type I: Complete Coding and Diagnostic Guide

1. Introduction

Bipolar disorder type I represents one of the most significant and challenging psychiatric conditions in contemporary clinical practice. Characterized by the presence of manic or mixed episodes, this episodic mood disorder profoundly affects the functionality, quality of life, and well-being of affected individuals. The fundamental distinction of type I in relation to other forms of bipolar disorder lies in the occurrence of at least one complete manic episode, which may or may not be accompanied by depressive episodes throughout the course of the disease.

The prevalence of bipolar disorder type I is significant in the general population, affecting people of all ages, although typical onset frequently occurs in late adolescence or early adulthood. The impact on public health is substantial, considering that manic episodes can lead to risky behaviors, severe occupational impairment, relationship breakdown, and in severe cases, need for hospitalization for the protection of the patient and others.

Correct coding using the 6A60 code from ICD-11 is critical for multiple reasons. First, it enables appropriate epidemiological recording, facilitating prevalence studies and mental health resource planning. Second, it ensures precise communication among health professionals, essential for continuity of care. Third, it ensures appropriate access to specialized treatments and mood-stabilizing medications. Finally, correct documentation is fundamental for legal, administrative, and health service coverage issues, protecting both the patient and the professional.

2. Correct ICD-11 Code

Code: 6A60

Description: Bipolar disorder type I

Parent category: Bipolar disorder or related disorders

Official definition: Bipolar disorder type I is an episodic mood disorder defined by the occurrence of one or more manic or mixed episodes. A manic episode constitutes an extreme mood state that lasts for at least one week, unless shortened by a treatment intervention, characterized by euphoria, irritability or expansiveness and by increased activity or a subjective experience of increased energy.

Characteristic symptoms include rapid speech or pressure to speak, flight of ideas, increased self-esteem or grandiosity, decreased need for sleep, distractibility, impulsive or reckless behavior, and rapid shifts between different mood states, known as mood lability.

A mixed episode presents several prominent manic symptoms and several prominent depressive symptoms that occur simultaneously or alternate very rapidly, from one day to the next or within the same day. Symptoms must include an altered mood state and be present most of the day, almost every day, for at least two weeks, unless shortened by therapeutic intervention. Although diagnosis can be established based on a single manic or mixed episode, typically these episodes alternate with depressive episodes over the course of the disorder.

3. When to Use This Code

Code 6A60 should be used in specific clinical situations where the diagnostic criteria for bipolar I disorder are clearly met. Below, we present detailed practical scenarios:

Scenario 1: First Manic Episode A 24-year-old patient presents to the emergency department brought by family members due to atypical behavior over the past eight days. Reports feeling "on top of the world," sleeping only two hours per night without feeling tired, speaking incessantly about multiple grandiose business projects he plans to start simultaneously. Spent all savings on impulsive purchases and is irritable when questioned. No previous history of similar or depressive episodes. This is the classic scenario for coding 6A60, as a single manic episode is sufficient for diagnosis.

Scenario 2: Recurrent Manic Episode with Depressive History A 35-year-old patient with a history of two major depressive episodes at ages 28 and 32, appropriately treated, now presents with seven days of intense euphoria, hypersexuality, excessive spending, accelerated speech, and reduced sleep need to three hours per night. The presence of a manic episode, regardless of previous depressive history, confirms the diagnosis of bipolar I disorder.

Scenario 3: Mixed Episode A 42-year-old patient presents with three weeks of rapidly alternating symptoms between euphoria with increased energy and grandiose ideas, and periods of intense crying, hopelessness, and suicidal ideation, sometimes within the same day. Maintains significant reduction in sleep need and pressured speech even during periods of depressed mood. This pattern of simultaneous or rapidly alternating manic and depressive symptoms characterizes a mixed episode, justifying code 6A60.

Scenario 4: Mania with Psychotic Features A 29-year-old hospitalized patient presenting with delusions of grandeur, believing himself to be a world leader chosen to save humanity, with euphoric mood, complete insomnia for five days, disorganized speech, and agitated behavior. The presence of psychotic features during a manic episode does not alter the primary diagnosis of bipolar I disorder, making code 6A60 appropriate with additional specifiers for psychotic features.

Scenario 5: Antidepressant-Induced Mania A 38-year-old patient undergoing treatment for depression develops a complete manic episode after starting an antidepressant. Although initially precipitated by medication, if the episode meets all criteria for mania and persists beyond discontinuation of the antidepressant, the diagnosis of bipolar I disorder is appropriate, using code 6A60.

Scenario 6: Current Remission with Confirmed History A 50-year-old patient in outpatient follow-up, currently euthymic and stable for two years with mood stabilizer use, but with documented history of three manic episodes and two depressive episodes over his lifetime. Code 6A60 remains appropriate to document the established diagnosis, even during periods of remission.

4. When NOT to Use This Code

It is fundamental to recognize situations where code 6A60 is not appropriate, avoiding diagnostic and coding errors:

Bipolar Disorder Type II: If the patient presents a history of major depressive episodes and hypomanic episodes, but has never experienced a complete or mixed manic episode, the correct code is 6A61. The crucial distinction is that hypomania, although presenting symptoms similar to mania, is less severe, does not cause marked functional impairment, does not require hospitalization, and does not present psychotic features. A patient who had multiple depressive episodes and periods of four days with elevated mood, decreased need for sleep, and increased energy, but was able to maintain their professional and social activities, should be coded as 6A61, not 6A60.

Cyclothymic Disorder: When the patient presents chronic mood fluctuations with numerous periods of hypomanic symptoms and depressive symptoms that do not meet full criteria for manic, mixed, or major depressive episodes, the appropriate code is 6A62. For example, a patient with a two-year history of frequent alterations between periods of slightly elevated mood with increased energy and periods of low mood with decreased interest, but without episodes that meet full diagnostic criteria, should not receive code 6A60.

Substance-Induced Disorders: If manic symptoms occur exclusively during intoxication or withdrawal from substances and there is no evidence of episodes independent of substance use, the primary diagnosis should reflect the substance-related disorder, not bipolar disorder type I.

General Medical Conditions: Manic symptoms secondary to medical conditions such as hyperthyroidism, brain tumors, multiple sclerosis, or high-dose corticosteroid use should be coded as mood disorder due to medical condition, not as 6A60.

Schizoaffective Disorder: If the patient presents prominent psychotic symptoms that persist for significant periods in the absence of mood alterations, the diagnosis of schizoaffective disorder may be more appropriate than bipolar disorder type I.

5. Step-by-Step Coding Process

Step 1: Assess Diagnostic Criteria

Confirmation of bipolar I disorder diagnosis requires comprehensive clinical evaluation. Begin with detailed psychiatric interview, exploring the longitudinal history of mood symptoms. Specifically inquire about episodes of elevated, expansive, or irritable mood, increased energy or activity, and characteristic symptoms of mania.

Utilize structured assessment instruments when available, such as the Young Mania Rating Scale (YMRS) to quantify the severity of manic symptoms, and the Mood Disorder Questionnaire (MDQ) as a screening tool. Interview with family members or close contacts is often essential, as patients in mania may not recognize the abnormality of their behavior.

Carefully document the duration of symptoms, functional impact, presence of psychotic features, and whether there is alternation with depressive episodes. Also assess family history of mood disorders, which is frequently positive in cases of bipolar disorder.

Step 2: Verify Specifiers

After confirming the primary diagnosis, identify relevant specifiers that provide important additional information. Determine the current episode state: currently manic, currently depressive, currently mixed, or in remission. Assess severity: mild, moderate, or severe, with or without psychotic features.

Identify special patterns such as rapid cycling (four or more mood episodes in one year), which has important therapeutic implications. Document whether there are psychotic features congruent or incongruent with mood, melancholic features during depressive episodes, or atypical features.

Consider contextual factors such as onset in the perinatal period, which may influence clinical management. These specifiers, although they do not change the primary code 6A60, are essential for complete documentation and therapeutic planning.

Step 3: Differentiate from Other Codes

6A61 - Bipolar II Disorder: The fundamental difference is the presence of a complete manic episode in type I versus only hypomanic episodes in type II. If the patient has never experienced an episode that met all criteria for duration (at least one week or any duration if hospitalization was necessary), severity, and functional impact of mania, the diagnosis is type II. The presence of a single manic episode during lifetime definitively changes the diagnosis to type I.

6A62 - Cyclothymic Disorder: Cyclothymic disorder is characterized by chronic mood instability with numerous periods of hypomanic and depressive symptoms that do not reach threshold for complete episodes. If the patient has presented with at least one complete manic or mixed episode, the diagnosis is bipolar I disorder, not cyclothymia. Cyclothymia may be viewed as a milder and chronic bipolar spectrum disorder.

Other Conditions: Differentiate from major depressive disorder (absence of manic or hypomanic episodes), primary psychotic disorders (predominant psychotic symptoms without clear relationship to mood episodes), and personality disorders with affective instability (chronic pattern without distinct episodes).

Step 4: Required Documentation

Adequate documentation should include:

Mandatory Information Checklist:

• Detailed description of manic symptoms present
• Precise duration of current episode and previous episodes
• Functional impact in occupational, social, and personal areas
• Presence or absence of psychotic features
• History of depressive episodes, if applicable
• History of previous treatments and response
• Exclusion of medical causes or substance-induced
• Risk assessment (suicide, aggression, risk-taking behaviors)
• Family history of mood disorders
• Current state: in episode or in remission

Clearly record code 6A60 in clinical documentation, accompanied by relevant specifiers. Document the diagnostic reasoning, especially in complex cases where differential diagnosis was challenging.

6. Complete Practical Example

Clinical Case

Initial Presentation: Marcos, 32 years old, mathematics teacher, is brought to the psychiatric emergency department by his wife and brother. Nine days ago, he began presenting significant behavioral changes. Initially, his wife noticed that he was exceptionally cheerful and talkative, attributing this to a successful school project. However, the behavior progressively intensified.

Over the last five days, Marcos sleeps only one to two hours per night, stating he does not feel the need to sleep because he is "energized by the mission to revolutionize the global educational system". He has been writing incessantly a "new revolutionary pedagogical method", producing over one hundred pages of disorganized text. He speaks rapidly, jumping from one subject to another, making it difficult to follow his reasoning.

He spent significant amounts purchasing electronic equipment and materials that "will be necessary to implement his educational revolution". When questioned by his wife about the expenses, he became irritable and verbally aggressive, behavior atypical for him. Yesterday, he presented himself to the school principal with a grandiose plan to reformulate the entire curriculum, speaking in a pressured and agitated manner. The principal, concerned, contacted the family.

Evaluation Performed: On emergency evaluation, Marcos presents visibly agitated, with rapid and pressured speech. He describes his mood as "fantastic, better than ever". He exhibits marked grandiosity, stating that "he was chosen to transform global education" and that "international institutions will soon seek him out". He denies any problems, insisting that he is "finally realizing his potential".

His wife provides essential collateral information: Marcos had no previous psychiatric history until two years ago, when he had a three-month depressive episode following his father's death, treated with psychotherapy and antidepressant, with good response. After remission, he discontinued treatment. The current episode began abruptly nine days ago, without a clear precipitating factor.

Physical examination and laboratory tests (thyroid function, electrolytes, complete blood count, toxicology screening) were performed and revealed no abnormalities that would explain the presentation. There is no substance use. Family history reveals that Marcos's mother had multiple psychiatric hospitalizations for "serious nervous problems", without confirmed diagnosis available.

Diagnostic Reasoning: The clinical presentation clearly shows a manic episode: elevated and expansive mood, marked grandiosity, marked decrease in need for sleep without fatigue, pressured speech, flight of ideas, increased goal-directed activity, impulsive behavior (excessive spending), and irritability. The duration of nine days meets the minimum temporal criterion of one week. The functional impact is significant, with impairment in work and relationships.

Although Marcos has a history of a previous depressive episode, the presence of a complete manic episode definitively establishes the diagnosis of bipolar I disorder. The absence of medical causes or substance-induced causes was confirmed. The positive family history for severe mood disorder is consistent with the diagnosis.

Coding Justification:

Primary Code: 6A60 - Bipolar I Disorder

The coding 6A60 is appropriate for the following reasons:

1. Presence of complete manic episode meeting all diagnostic criteria
2. Duration exceeding one week (nine days)
3. Characteristic symptoms clearly present: elevated mood, grandiosity, decreased need for sleep, pressured speech, flight of ideas, impulsive behavior, irritability
4. Significant functional impact
5. Exclusion of other causes (medical, substances)
6. History of previous depressive episode, consistent with the typical course of the disorder

Specifiers:

• Current manic episode
• Severity: moderate to severe (without psychotic features)
• First manic episode (although with history of previous depressive episode)

Complementary Coding: There is no need for additional codes in this case, as there are no identified medical or psychiatric comorbidities requiring separate coding.

Documentation: "32-year-old patient presenting with acute manic episode of nine days duration, characterized by euphoric mood, grandiosity, marked decrease in need for sleep, pressured speech, impulsive behavior and irritability. History of major depressive episode two years ago. Laboratory tests without abnormalities. Diagnosis: Bipolar I Disorder (ICD-11: 6A60), current manic episode, moderate to severe severity. Hospitalization indicated for stabilization and initiation of pharmacological treatment."

7. Related Codes and Differentiation

Within the Same Category

6A61: Bipolar Disorder Type II

When to use 6A61 vs. 6A60: Use 6A61 when the patient presents a history of at least one major depressive episode and at least one hypomanic episode, but has never experienced a complete or mixed manic episode. Hypomania differs from mania by being less severe, shorter in duration (minimum of four days versus seven days), without psychotic features, and without causing marked functional impairment or need for hospitalization.

Main difference: The fundamental distinction is the presence versus absence of a complete manic episode. A single manic episode over a lifetime changes the diagnosis from type II to type I. Patients with type II may have more frequent and severe depressive episodes than hypomanic ones, but the absence of complete mania defines type II.

Differentiating example: Patient with a history of three severe depressive episodes and two five-day periods with elevated mood, decreased need for sleep and increased productivity, but who was able to maintain their activities and relationships without significant impairment = 6A61. If this same patient later develops a ten-day episode with similar symptoms but with intensity causing marked functional impairment, significant impulsive spending and need for intervention = diagnosis changes to 6A60.

6A62: Cyclothymic Disorder

When to use 6A62 vs. 6A60: Use 6A62 when the patient presents chronic mood instability for at least two years (one year in children and adolescents), with numerous periods of hypomanic symptoms and depressive symptoms that do not meet full criteria for hypomanic, manic, or major depressive episodes.

Main difference: Cyclothymic disorder is characterized by chronic and persistent mood fluctuations with subsyndromal symptoms, while bipolar disorder type I is defined by distinct and clearly demarcated episodes that meet complete diagnostic criteria. Cyclothymia does not include complete manic, mixed, or major depressive episodes.

Differentiating example: Patient with three years of history of frequent mood changes, alternating between periods of a few days with slightly elevated mood and increased energy, and periods of low mood and decreased interest, but always able to function reasonably well = 6A62. If this patient develops a complete manic episode lasting one week = diagnosis changes to 6A60.

Differential Diagnoses

Recurrent Major Depressive Disorder: Can be confused with bipolar disorder type I when the patient presents in a depressive episode and the history of mania is not adequately investigated. Always inquire about previous episodes of elevated mood, decreased need for sleep, and atypical expansive behavior.

Borderline Personality Disorder: Affective instability in borderline personality disorder can be confused with rapid cycling or mixed episodes. However, in personality disorder, mood changes are typically reactive to interpersonal events, short-lived (hours), and occur within the context of a persistent pattern of instability in relationships and self-image.

Schizoaffective Disorder: When psychotic symptoms are prominent, there may be confusion with schizoaffective disorder. In bipolar disorder type I, psychotic symptoms occur exclusively during mood episodes and do not persist for prolonged periods when mood is stabilized.

Attention-Deficit/Hyperactivity Disorder (ADHD): In children and adolescents, hyperactivity, impulsivity, and distractibility of ADHD can be confused with mania. The distinction lies in the episodic nature of symptoms in bipolar disorder versus the chronic and persistent pattern in ADHD, in addition to the presence of clearly elevated or irritable mood in bipolar disorder.

8. Differences with ICD-10

Equivalent ICD-10 Code: In ICD-10, bipolar disorder type I was coded as F31 (Bipolar affective disorder), with subdivisions based on the current episode (F31.0 to F31.9).

Major Changes in ICD-11:

ICD-11 introduced significant changes in the classification of bipolar disorders. First, the nomenclature became more specific, clearly distinguishing between type I and type II from the initial coding level, whereas in ICD-10 this distinction was less explicit.

The definition of mixed episode was refined in ICD-11, requiring that prominent manic and depressive symptoms occur simultaneously or alternate very rapidly, with a minimum duration of two weeks. In ICD-10, the criteria for mixed episode were less specific.

ICD-11 eliminated the category of "hypomania" as an independent diagnosis, integrating it as a feature of bipolar disorder type II. The hierarchical structure became clearer, with bipolar disorder type I (6A60) clearly positioned within the category of bipolar or related disorders.

Specifiers were standardized and expanded, allowing more precise coding of the current state, severity, and special features such as rapid cycling, psychotic features, and melancholic or atypical features.

Practical Impact:

The transition from ICD-10 to ICD-11 requires that professionals familiarize themselves with the new coding structure and refined diagnostic criteria. Clinical documentation should be more detailed, clearly specifying the type of episode, its duration, and characteristics.

For health systems, the change facilitates the collection of more precise epidemiological data and international comparisons, since ICD-11 was developed with greater global participation and field testing. Compatibility with electronic medical record systems was also considered in the development of ICD-11.

Professionals should review diagnoses established under ICD-10 and ensure that they meet ICD-11 criteria, particularly in borderline or complex cases. Continuing education on the changes is essential for proper implementation.

9. Frequently Asked Questions

How is type I bipolar disorder diagnosed?

The diagnosis is essentially clinical, based on a detailed psychiatric interview that evaluates the longitudinal history of mood symptoms. The professional should identify the presence of at least one manic or mixed episode that meets specific diagnostic criteria: minimum duration of one week (or any duration if hospitalization is necessary), elevated, expansive, or irritable mood, increased energy or activity, and at least three additional characteristic symptoms (four if mood is only irritable). Information from family members or close persons is frequently crucial, as patients in mania may not recognize the abnormality of their state. There are no laboratory or imaging tests that confirm the diagnosis, but these are performed to exclude medical causes or those induced by substances that may mimic mania.

Is treatment available in public health systems?

Treatment for type I bipolar disorder is generally available in public health systems in most countries, although access and quality may vary. Treatment includes mood-stabilizing medications such as lithium, valproate, and atypical antipsychotics, which are frequently included in essential medication lists. Outpatient and inpatient mental health services for acute cases are generally part of the public network. However, the availability of specialized psychotherapies, psychoeducational programs, and psychosocial rehabilitation services may be more limited in some contexts. Patients should seek specific information about resources available in their region through local health services or support organizations for people with mental disorders.

How long does treatment last?

Type I bipolar disorder is a chronic condition that typically requires long-term treatment, often throughout life. After an acute manic episode, the stabilization phase generally lasts several weeks to months. However, maintenance treatment with mood stabilizers is generally recommended indefinitely to prevent recurrences, especially after multiple episodes. Studies demonstrate that discontinuation of treatment is associated with high risk of relapse. The duration and intensity of psychotherapeutic follow-up vary according to individual needs, but psychoeducational interventions and maintenance psychotherapy are frequently recommended. Decisions about treatment duration should be individualized, considering factors such as number of previous episodes, severity, treatment response, and patient preferences.

Can this code be used in medical certificates?

Yes, code 6A60 can and should be used in medical certificates when appropriate, especially in contexts where specific diagnostic documentation is necessary to justify work leave, benefit requests, or special accommodations. However, considerations regarding confidentiality and stigma should be weighed. In some situations, it may be appropriate to use more general descriptions such as "mood disorder" or "psychiatric condition," depending on the context and applicable health data protection laws. The professional should discuss with the patient the level of diagnostic specificity to be included in documents that will be shared with employers or other institutions, balancing the need for adequate documentation with the protection of privacy and prevention of discrimination.

What is the difference between type I and type II bipolar disorder?

The fundamental difference lies in the severity of elevated mood episodes. In type I, the patient presents at least one complete manic episode, characterized by severe symptoms that cause marked functional impairment, may include psychotic features, and frequently require hospitalization. In type II, the patient presents hypomanic episodes, which are less severe, of shorter duration, do not cause significant functional impairment, and do not include psychotic features. Both types include depressive episodes, but in type II the depressive episodes tend to be more frequent and prominent. The presence of a single manic episode throughout life establishes the diagnosis of type I, even if the patient has had multiple hypomanic and depressive episodes previously.

Can people with type I bipolar disorder work normally?

Many people with type I bipolar disorder are able to maintain productive professional activities, especially when the disorder is adequately treated and stabilized. During periods of remission with effective treatment, functionality can be completely preserved. However, during acute episodes (manic, mixed, or depressive), work capacity is typically compromised, and temporary leave may be necessary. Some patients may benefit from adjustments in the work environment, such as schedule flexibility, reduction of stressors, or modification of responsibilities during periods of greater vulnerability. Occupational prognosis improves significantly with adequate treatment, medication adherence, psychotherapy, stress management, and early detection of relapse signs. Support from informed employers and workplace mental health policies also contribute to better occupational outcomes.

Is type I bipolar disorder hereditary?

Type I bipolar disorder has a significant genetic component. Family and twin studies demonstrate that the condition tends to run in families, and the risk is greater in first-degree relatives of people with bipolar disorder. However, heritability is not absolute—it is not a condition determined by a single gene, but results from the complex interaction of multiple genes with environmental factors. Having a family member with bipolar disorder increases the risk, but does not determine that the person will develop the condition. Environmental factors such as stress, trauma, substance use, and sleep patterns also play an important role in the development and course of the disorder. People with significant family history may benefit from surveillance for early signs and rapid intervention if symptoms emerge.

Is it possible to prevent future episodes?

Although it is not possible to completely prevent all future episodes, effective prevention strategies can significantly reduce the frequency and severity of recurrences. Consistent adherence to medication treatment with mood stabilizers is the most effective preventive intervention. Maintenance of regular routines, especially sleep, is fundamental, as sleep irregularities are common triggers for episodes. Stress management through techniques such as mindfulness, regular exercise, and psychotherapy also contribute to stability. Early detection of relapse warning signs, through self-monitoring and regular communication with health professionals, allows rapid intervention before complete episodes develop. Avoiding alcohol and other substances, which can destabilize mood, is essential. Psychoeducational programs that teach patients and family members about the disorder, treatment, and symptom management significantly improve long-term outcomes.

---

Conclusion:

Proper coding of type I bipolar disorder using ICD-11 code 6A60 requires in-depth understanding of diagnostic criteria, ability to differentiate similar conditions, and detailed clinical documentation. This episodic mood disorder, characterized by the presence of manic or mixed episodes, represents a significant condition that profoundly impacts the lives of affected individuals. Accurate recognition, correct coding, and appropriate treatment are fundamental to improving prognosis and quality of life for patients. Health professionals should remain updated on ICD-11 criteria and apply them consistently in clinical practice, ensuring effective communication, adequate epidemiological recording, and appropriate access to available treatment resources.

External References

This article was developed based on reliable scientific sources:

1. 🌍 WHO ICD-11 - Bipolar disorder type I
2. 🔬 PubMed Research on Bipolar disorder type I
3. 🌍 WHO Health Topics
4. 📋 NICE Mental Health Guidelines
5. 📊 Clinical Evidence: Bipolar disorder type I
6. 📋 Ministry of Health - Brazil
7. 📊 Cochrane Systematic Reviews

References verified on 2026-02-02